Trial: 202010127

First in Human Phase 1/2 Trial of ELI-002 Immunotherapy as Treatment for Subjects with Kirsten Rat Sarcoma (KRAS) Mutated Pancreatic Ductal Adenocarcinoma and Other Solid Tumors

Phase

I/II

Principal Investigator

Park, Haeseong

Disease Site

Colon; Lung; Other Digestive Organ; Ovary; Pancreas; Rectum

Learn more about this study at: clinicaltrials.gov